xmlns:atom="http://www.w3.org/2005/Atom"
2.—(1) The Medical Devices (Consultation Requirements) (Fees) Regulations 1995(1) are amended as follows.
(2) In regulation 3 (fees)—
(a)in paragraph (1)—
(i)in sub-paragraph (a), for “£4,141” substitute “”£4,374”, and
(ii)in sub-paragraph (b), for “£9,653” substitute “£10,197”;
(b)in paragraph (2)—
(i)in sub-paragraph (a), for “£819” substitute “£865”, and
(ii)in sub-paragraph (b), for “£2,291” substitute “£2,420”;
(c)in paragraph (3)—
(i)in sub-paragraph (a), for “£4,141” substitute “£4,374”, and
(ii)in sub-paragraph (b), for “”£9,653” substitute “£10,197”;
(d)in paragraph (4)—
(i)in sub-paragraph (a), for “£819” substitute “£865”, and
(ii)in sub-paragraph (b), for “£2,291” substitute “ £2,420”;
(e)in paragraph (5)—
(i)in sub-paragraph (a), for “£42,352” substitute “£44,741”, and
(ii)in sub-paragraph (b), for “£10,515” substitute “£11,108”.
(3) In paragraph (2) of regulation 3A (fees for pre-consultation meetings)—
(a)in sub-paragraph (a), for “£750” substitute “£792”;
(b)in sub-paragraph (b), for “£950” substitute “£1,004”;
(c)in sub-paragraph (c) for “£1,300” substitute £1,373”; and
(d)for “(a) if the advice provided at that meeting consists of advice in connection with quality, safety and clinical development, £1,650” substitute—
“(d)if the advice provided at that meeting consists of advice in connection with quality, safety and clinical development, £1,173”.
S.I. 1995/449; relevant amending instrument is S.I. 2007/803.